Insmed Inc (INSM)
73.15
-0.66
(-0.89%)
USD |
NASDAQ |
Nov 22, 16:00
73.10
-0.05
(-0.07%)
After-Hours: 20:00
Insmed Cash from Operations (Quarterly): -180.92M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -180.92M |
| June 30, 2024 | -122.95M |
| March 31, 2024 | -184.04M |
| December 31, 2023 | -130.82M |
| September 30, 2023 | -136.33M |
| June 30, 2023 | -122.79M |
| March 31, 2023 | -146.30M |
| December 31, 2022 | -103.15M |
| September 30, 2022 | -89.83M |
| June 30, 2022 | -102.30M |
| March 31, 2022 | -105.16M |
| December 31, 2021 | -84.13M |
| September 30, 2021 | -75.44M |
| June 30, 2021 | -75.44M |
| March 31, 2021 | -128.28M |
| December 31, 2020 | -66.79M |
| September 30, 2020 | -58.67M |
| June 30, 2020 | -35.95M |
| March 31, 2020 | -57.94M |
| December 31, 2019 | -44.40M |
| September 30, 2019 | -52.37M |
| June 30, 2019 | -80.03M |
| March 31, 2019 | -73.85M |
| December 31, 2018 | -70.16M |
| September 30, 2018 | -65.49M |
| Date | Value |
|---|---|
| June 30, 2018 | -54.91M |
| March 31, 2018 | -67.41M |
| December 31, 2017 | -48.22M |
| September 30, 2017 | -38.24M |
| June 30, 2017 | -36.25M |
| March 31, 2017 | -36.91M |
| December 31, 2016 | -57.96M |
| September 30, 2016 | -30.98M |
| June 30, 2016 | -28.24M |
| March 31, 2016 | -29.53M |
| December 31, 2015 | -27.55M |
| September 30, 2015 | -24.03M |
| June 30, 2015 | -24.24M |
| March 31, 2015 | -24.88M |
| December 31, 2014 | -12.93M |
| September 30, 2014 | -20.90M |
| June 30, 2014 | -17.93M |
| March 31, 2014 | -12.65M |
| December 31, 2013 | -14.06M |
| September 30, 2013 | -16.29M |
| June 30, 2013 | -5.112M |
| March 31, 2013 | -11.21M |
| December 31, 2012 | -8.926M |
| September 30, 2012 | -9.188M |
| June 30, 2012 | -7.286M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-184.04M
Minimum
Mar 2024
-35.95M
Maximum
Jun 2020
-102.58M
Average
-102.72M
Median
Cash from Operations (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 43.71M |
| Amicus Therapeutics Inc | -22.97M |
| Collegium Pharmaceutical Inc | -8.999M |
| enVVeno Medical Corp | -4.276M |
| Fulcrum Therapeutics Inc | -19.07M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.003B |
| Cash from Financing (Quarterly) | 397.20M |
| Free Cash Flow | -636.03M |
| Free Cash Flow Per Share (Quarterly) | -1.063 |
| Free Cash Flow to Equity (Quarterly) | 31.84M |
| Free Cash Flow to Firm (Quarterly) | -163.45M |
| Free Cash Flow Yield | -5.59% |